Refining the Who, When, and How of SGLT2-Inhibitors of Patients with HFpEF

This episode provides an in-depth analysis of the EMPEROR-Preserved study, including the main components of the study methodology, patient population, efficacy and safety findings, and overall clinical application. A review of SGLT2 inhibitors in HF is also covered, along with a discussion of ongoing studies. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.